【24h】

An enantioselective assay for (+/-)-modafinil.

机译:(+/-)-莫达非尼的对映选择性测定。

获取原文
获取原文并翻译 | 示例
           

摘要

Enantiomers of modafinil, (diphenylmethyl)sulphinyl-2-acetamide, were separated by an amylose tris[(S)-1-phenylethylcarbamate] chiral stationary phase, using acetonitrile: water (25:75 v/v) as mobile phase, with excellent selectivity (alpha=1.4) and resolution factors (R(s)=1.5). The assay involved a solid-phase extraction of the enantiomers of modafinil from plasma using a C(18) Cartridge. A good linear relationship was obtained in the concentration of 0.15-3 microg ml(-1) for each enantiomer. The method developed is sufficiently accurate and precise to be used for clinical samples and has a good selectivity with the two main circulating metabolites: the (diphenylmethyl)sulphinyl-2-acetic acid and (diphenylmethyl)sulphonyl-2-acetamide. The use of a polysaccharide-based column on multimodal elution was explored in developing the method.
机译:使用乙腈:水(25:75 v / v)作为流动相,通过直链淀粉三[[(S)-1-苯基乙基氨基甲酸酯)]手性固定相分离莫达非尼的对映异构体((二苯基甲基)亚磺酰基-2-乙酰胺)选择性(alpha = 1.4)和分辨率因子(R(s)= 1.5)。该测定涉及使用C(18)色谱柱从血浆中固相萃取莫达非尼的对映体。每种对映体的浓度为0.15-3 microg ml(-1)时,可获得良好的线性关系。所开发的方法具有足够的准确性和精确性,可用于临床样品,并且对两种主要的循环代谢物具有良好的选择性:(二苯甲基)亚磺酰基-2-乙酸和(二苯甲基)磺酰基-2-乙酰胺。在开发该方法时,探讨了使用基于多糖的色谱柱进行多峰洗脱。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号